This company seems to have been delisted
Reason: Acquired by Amgen
Last recorded trade on: December 8, 2023
Source: https://www.prnewswire.com/news-releases/amgen-completes-acquisition-of-horizon-therapeutics-plc-301949517.html
Reason: Acquired by Amgen
Last recorded trade on: December 8, 2023
Source: https://www.prnewswire.com/news-releases/amgen-completes-acquisition-of-horizon-therapeutics-plc-301949517.html
Horizon Therapeutics
HZNP
HK$904.21
Share price
0.00%
Change (1 day)
4.95%
Change (1 year)
Categories
Horizon Therapeutics (HZNP) - Cash on Hand
Cash on Hand as of June 2023 : HK$19.16 Billion
According to Horizon Therapeutics
's latest financial reports the company has HK$19.16 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Horizon Therapeutics - Cash on Hand chart (from 2009 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | HK$18.38 B | 49.18% |
| 2021-12-31 | HK$12.32 B | -23.58% |
| 2020-12-31 | HK$16.12 B | 92.36% |
| 2019-12-31 | HK$8.38 B | 11.65% |
| 2018-12-31 | HK$7.50 B | 27.89% |
| 2017-12-31 | HK$5.87 B | 48.71% |
| 2016-12-31 | HK$3.94 B | -40.75% |
| 2015-12-31 | HK$6.66 B | 292.57% |
| 2014-12-31 | HK$1.69 B | 171.95% |
| 2013-12-31 | HK$0.62 B | -22.65% |
| 2012-12-31 | HK$0.80 B | 478.18% |
| 2011-12-31 | HK$0.13 B | 233.04% |
| 2010-12-31 | HK$41.89 M | -24.53% |
| 2009-12-31 | HK$55.51 M | -48.93% |
| 2008-12-31 | HK$0.10 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | HK$93.08 B | 385.79% | 🇺🇸 USA |
 | HK$43.95 B | 129.41% | 🇬🇧 UK |
 | HK$159.20 B | 730.84% | 🇺🇸 USA |
 | HK$5.36 B | -72.01% | 🇮🇳 India |
 | HK$106.42 B | 455.42% | 🇺🇸 USA |